Six million lives and counting were lost. Nearly 200,000 U.S. businesses closed. K-12 students are five months behind in math and four months behind in reading, likely creating a lasting achievement gap.

There is a silver lining: a dramatic increase in the speed of medical innovation, with the timeframe for new solutions in some cases compressed from years to weeks or even days. And this new environment may indeed be a new normal.

In a recent survey of more than 100 healthcare leaders from medical technology and pharmaceutical companies, health systems, and payers, nine out of ten respondents said, “The pandemic will fundamentally change the way they do business, requiring new products, services, processes and business models.”

This white paper highlights five trends in healthcare and life sciences that present both opportunities and challenges in a post-pandemic era.